Compare EW & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EW | FANG |
|---|---|---|
| Founded | 1958 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5B | 45.9B |
| IPO Year | 2000 | 2012 |
| Metric | EW | FANG |
|---|---|---|
| Price | $86.18 | $151.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 19 |
| Target Price | $95.83 | ★ $187.72 |
| AVG Volume (30 Days) | ★ 3.0M | 1.8M |
| Earning Date | 02-10-2026 | 11-03-2025 |
| Dividend Yield | N/A | ★ 2.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.33 | ★ 14.37 |
| Revenue | $5,883,800,000.00 | ★ $14,626,000,000.00 |
| Revenue This Year | $14.29 | $43.88 |
| Revenue Next Year | $9.68 | N/A |
| P/E Ratio | $37.32 | ★ $10.34 |
| Revenue Growth | 10.60 | ★ 59.73 |
| 52 Week Low | $65.94 | $114.00 |
| 52 Week High | $87.89 | $180.91 |
| Indicator | EW | FANG |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 51.04 |
| Support Level | $85.79 | $144.80 |
| Resistance Level | $87.44 | $153.19 |
| Average True Range (ATR) | 1.38 | 4.05 |
| MACD | 0.08 | -0.84 |
| Stochastic Oscillator | 78.25 | 38.61 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.